# Useful info

Every person with advanced cancer who is treated at MSK undergoes genetic sequencing of their tumor with MSK-IMPACTâ„¢, a tool that looks for mutations in 400-plus cancer-associated genes. Since sequencing started in 2014, MSK has compiled genetic tumor profiles from more than 50,000 patients.
